biperiden has been researched along with Focal Neurologic Deficits in 2 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MEDINA, C | 1 |
| KRAMER, MD | 1 |
| KURLAND, AA | 1 |
| ALLEVA, PM | 1 |
2 other studies available for biperiden and Focal Neurologic Deficits
| Article | Year |
|---|---|
Biperiden in the treatment of phenothiazine-induced extrapyramidal reactions.
Topics: Biperiden; Extrapyramidal Tracts; Humans; Neurologic Manifestations; Parasympathomimetics; Phenothia | 1962 |
[AKINETON IN PARKINSONISM CAUSED BY DRUGS].
Topics: Anti-Allergic Agents; Biperiden; Haloperidol; Histamine H1 Antagonists; Movement Disorders; Neurolog | 1963 |